BCG vaccination against tuberculosis: past disappointments and future hopes
- 1 October 1995
- journal article
- editorial
- Published by Elsevier in Trends in Microbiology
- Vol. 3 (10) , 397-401
- https://doi.org/10.1016/s0966-842x(00)88986-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A strategy to improve the efficacy of vaccination against tuberculosis and leprosyPublished by Elsevier ,2003
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected childrenThe Pediatric Infectious Disease Journal, 1993
- Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.The Journal of Experimental Medicine, 1993
- Treatment of hepatic candidosis with liposomal amphotericin B in patient with acute leukaemiaThe Lancet, 1991
- An immunogenetic view of delayed type hypersensitivityTubercle, 1991
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- The present and future role of BCG vaccine in tuberculosis controlBiologicals, 1990
- What is BCG?Tubercle, 1983
- Influence of the Virulence of Mycobacterium tuberculosis on Protection Induced by Bacille Calmette-Guerin in Guinea PigsThe Journal of Infectious Diseases, 1981